This paper is only available as a PDF. To read, Please Download here.
Painful diabetic neuropathy (PDN) is an intractable and debilitating disease characterized
by neuropathic pain and small-fiber degeneration. Given the prevalence of the disease,
there is a dire need to identify new targets for the development of disease-modifying
therapeutics for PDN. In patients with PDN, dorsal root ganglion (DRG) nociceptors
become hyperexcitable and eventually degenerate, but the molecular mechanism underlying
the phenomenon is unknown. We aim to identify the gene expression profile of the DRG
neurons in PDN pathology to facilitate the discovery of novel druggable targets. Using
a well-established mouse model of PDN, mice were either fed a regular diet (RD) or
a high-fat diet (HFD) for 10 weeks. We used a single-cell RNA (scRNA-seq) sequencing
approach to capture the changes in the DRG in an unbiased fashion. As expected, analysis
of the scRNA-seq identified both neuronal and non-neuronal clusters and several differentially
expressed genes. Interestingly, we saw two closely related non-peptidergic clusters
expressing a Mas-related G protein-coupled receptor (Mrgprd). While there were no
differences in the expression of Mrgprd in one of the clusters (NP1 Type1), there
seemed to be a significant increase in the expression of Mrgprd in a cluster we refer
to as the NP1 Type2. To determine the functional relevance of the overexpression of
Mrgprd, we used in vivo 2-photon calcium imaging with Nav1.8 Cre-GCaMP6 animals fed
an RD or HFD and examined whether administration of β-alanine (a known agonist of
Mrgprd) in the hind paw would directly activate Mrgprd positive DRG neurons. We observed
an increase in the number, as well as an increase in the magnitude of response in
the HFD indicating the hyperexcitability of neurons expressing Mrgprd. Taken together,
our data highlights an important role of the Mrgprd receptor in the generation and
maintenance of hyperexcitability in a mouse model of PDN. NS104295-01.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal of PainAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2021 Published by Elsevier Inc.